ZEPP
Income statement / Annual
Last year (2025), Zepp Health Corporation's total revenue was $1.82 B,
an increase of 36.12% from the previous year.
In 2025, Zepp Health Corporation's net income was -$280.92 M.
See Zepp Health Corporation,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$1.82 B |
$1.33 B |
$352.63 M |
$615.72 M |
$968.72 M |
$931.73 M |
$840.95 M |
$578.52 M |
$303.20 M |
$234.24 M |
| Cost of Revenue |
$1.10 B
|
$820.57 M
|
$260.33 M
|
$496.36 M
|
$766.36 M
|
$738.72 M
|
$628.59 M
|
$429.43 M
|
$229.99 M
|
$192.68 M
|
| Gross Profit |
$711.63 M
|
$512.88 M
|
$92.30 M
|
$119.36 M
|
$202.37 M
|
$193.01 M
|
$212.36 M
|
$149.09 M
|
$73.21 M
|
$41.56 M
|
| Gross Profit Ratio |
0.39
|
0.38
|
0.26
|
0.19
|
0.21
|
0.21
|
0.25
|
0.26
|
0.24
|
0.18
|
| Research and Development Expenses |
$317.73 M
|
$337.07 M
|
$51.47 M
|
$76.86 M
|
$79.83 M
|
$77.92 M
|
$62.33 M
|
$41.77 M
|
$22.76 M
|
$19.91 M
|
| General & Administrative Expenses |
$0.00
|
$181.41 M
|
$26.78 M
|
$35.11 M
|
$258.35 M
|
$261.81 M
|
$0.00
|
$0.00
|
$114.88 M
|
$14.77 M
|
| Selling & Marketing Expenses |
$0.00
|
$339.19 M
|
$44.53 M
|
$68.31 M
|
$438.27 M
|
$358.66 M
|
$0.00
|
$0.00
|
$44.03 M
|
$4.00 M
|
| Selling, General & Administrative Expenses |
$582.64 M
|
$520.85 M
|
$71.26 M
|
$103.48 M
|
$696.62 M
|
$620.46 M
|
$60.22 M
|
$49.28 M
|
$158.91 M
|
$18.77 M
|
| Other Expenses |
$16.20 M
|
$0.00
|
$0.00
|
$0.00
|
-$588.65 M
|
-$530.60 M
|
$0.00
|
$0.00
|
-$135.39 M
|
$863.79 K
|
| Operating Expenses |
$916.56 M
|
$857.92 M
|
$122.73 M
|
$180.33 M
|
$187.81 M
|
$167.78 M
|
$122.55 M
|
$91.05 M
|
$46.28 M
|
$39.55 M
|
| Cost And Expenses |
$2.02 B
|
$1.68 B
|
$383.06 M
|
$676.69 M
|
$954.16 M
|
$906.50 M
|
$751.14 M
|
$520.48 M
|
$276.27 M
|
$232.23 M
|
| Interest Income |
$10.70 M
|
$26.81 M
|
$3.09 M
|
$1.83 M
|
$2.59 M
|
$6.68 M
|
$4.84 M
|
$1.84 M
|
$444.39 K
|
$113.47 K
|
| Interest Expense |
$39.94 M
|
$40.54 M
|
$6.75 M
|
$8.47 M
|
$6.96 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$31.71 M
|
$36.64 M
|
$7.69 M
|
$8.71 M
|
$8.04 M
|
$3.93 M
|
$2.49 M
|
$986.48 K
|
$550.05 K
|
$361.04 K
|
| EBITDA |
-$191.48 M |
-$345.66 M |
-$20.17 M |
-$38.18 M |
$31.53 M |
$42.40 M |
$96.88 M |
$62.34 M |
$28.95 M |
$4.70 M |
| EBITDA Ratio |
-0.11
|
-0.26
|
-0.06
|
-0.06
|
0.03
|
0.05
|
0.12
|
0.11
|
0.1
|
0.02
|
| Operating Income Ratio |
-0.11
|
-0.26
|
-0.09
|
-0.1
|
0.02
|
0.03
|
0.11
|
0.1
|
0.09
|
0.01
|
| Total Other Income/Expenses Net |
-$58.20 M
|
-$108.55 M
|
-$3.06 M
|
$8.23 M
|
$8.33 M
|
$12.55 M
|
$4.42 M
|
$3.59 M
|
$1.88 M
|
$2.05 M
|
| Income Before Tax |
-$263.13 M
|
-$453.59 M
|
-$33.49 M
|
-$52.74 M
|
$22.89 M
|
$37.78 M
|
$94.23 M
|
$61.63 M
|
$28.81 M
|
$4.07 M
|
| Income Before Tax Ratio |
-0.14
|
-0.34
|
-0.09
|
-0.09
|
0.02
|
0.04
|
0.11
|
0.11
|
0.1
|
0.02
|
| Income Tax Expense |
$17.79 M
|
$99.99 M
|
-$2.43 M
|
-$9.79 M
|
$1.67 M
|
$4.51 M
|
$11.27 M
|
$8.26 M
|
$4.09 M
|
$464.73 K
|
| Net Income |
-$280.92 M
|
-$554.13 M
|
-$31.13 M
|
-$42.85 M
|
$21.36 M
|
$33.13 M
|
$83.22 M
|
$53.97 M
|
$24.81 M
|
$3.60 M
|
| Net Income Ratio |
-0.15
|
-0.42
|
-0.09
|
-0.07
|
0.02
|
0.04
|
0.1
|
0.09
|
0.08
|
0.02
|
| EPS |
-283.04 |
-34.08 |
-0.28 |
-0.4 |
0.22 |
0.34 |
5.44 |
1.31 |
0.1 |
-0.5 |
| EPS Diluted |
-283.04 |
-34.08 |
-0.28 |
-0.4 |
0.21 |
0.33 |
5.12 |
1.24 |
0.0992 |
-0.51 |
| Weighted Average Shares Out |
$993.87 K
|
$16.18 M
|
$15.20 M
|
$15.39 M
|
$15.76 M
|
$15.53 M
|
$15.40 M
|
$13.98 M
|
$14.86 M
|
$14.86 M
|
| Weighted Average Shares Out Diluted |
$993.87 K
|
$16.18 M
|
$15.20 M
|
$15.39 M
|
$16.52 M
|
$16.27 M
|
$16.15 M
|
$14.06 M
|
$14.86 M
|
$14.86 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
